Evidence map›Paper›PMID 41024060›Full record

ArticleJournal of medical case reports2025

A new tip for early warning of catastrophic antiphospholipid syndrome and hemolysis, elevated liver enzymes, and low platelet count syndrome: a case report.

Ran Teng, Nan Zheng, Ruixuan Yu, Fengchan Xi

Abstract readCase Reports
In one paragraph

Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ran TengDepartment of Intensive Care Unit, Womens Hospital of Nanjing Medical University, Nanjing Women and Childrens Healthcare Hospital, Mochou Road, Nanjing, 210004, Jiangsu, China.
Nan ZhengDepartment of Intensive Care Unit, Womens Hospital of Nanjing Medical University, Nanjing Women and Childrens Healthcare Hospital, Mochou Road, Nanjing, 210004, Jiangsu, China.
Ruixuan YuDepartment of Critical Care Medicine, Zhongda Hospital Southeast University, Nanjing, Jiangsu, China.
Fengchan XiDepartment of Intensive Care Unit, Womens Hospital of Nanjing Medical University, Nanjing Women and Childrens Healthcare Hospital, Mochou Road, Nanjing, 210004, Jiangsu, China. xifengchan@aliyun.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHemolysis, elevated liver enzymes, and low platelet count syndrome and catastrophic antiphospholipid syndrome are severe complications of pregnancy with potentially life-threatening consequences. Currently, the timely recognition and management of pregnant women with hemolysis, elevated liver enzymes, and low platelet count syndrome and catastrophic antiphospholipid syndrome remains a challenge. CASE PRESENTATION: In this case, we describe a 28-year-old East Asian pregnant woman with a history of antiphospholipid syndrome who developed hemolysis, elevated liver enzymes, and low platelet count syndrome and catastrophic antiphospholipid syndrome after delivery at 36 weeks of pregnancy. The patient presented with multiple red spots on her extremities and despite receiving conventional therapy, her condition deteriorated rapidly postpartum leading to multiple organ dysfunction syndrome. Notably, the onset of multiple organ dysfunction syndrome occurred within a narrow timeframe of 11 hours.

conclusionThis case underscores the importance of the early warning value of skin manifestations. At the same time, it is crucial to closely monitor pregnant women with antiphospholipid syndrome both during and after delivery. Furthermore, the rapid onset and progression of multiple organ dysfunction syndrome highlight the critical need for prompt initiation of organ support measures in such situations.

Indexed as

Antiphospholipid SyndromeHELLP SyndromeMultiple Organ FailurePregnancy ComplicationsAdultFemaleHemolysisHumansPregnancyAntiphospholipid syndromeCatastrophic antiphospholipid syndromeHELLP syndromeMultiple organ dysfunction syndromePregnancy

Identifiers

PMID41024060
PMCPMC12482697

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.